Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 3 - Drugs for disorders of the metabolism
Patents for A61P 3 - Drugs for disorders of the metabolism (129,789)
10/2008
10/02/2008US20080242600 Oral bioavailability; intestine permeability; metabolism disorders such as obesity
10/02/2008US20080242596 Such as 2-(2-(allyloxymethyl)-4-chloro-5-(4-ethylbenzyl)phenyl)-6-(hydroxymethyl)tetrahydro-2H-pyran-3,4,5-triol; sodium dependent glucose cotransporter inhibitors; type 1 or type 2 diabetes and related disorders; combination formulations
10/02/2008US20080242595 Conjugate of insulin and vitamin B12 for oral delivery
10/02/2008US20080242593 Such as 2-(((9H-fluoren-9-yl)methoxy)carbonylamino)-3-(6-(2-ethylphenyl)pyridin-3-yl)propanoic acid; stability to proteolytic cleavage
10/02/2008US20080241961 Drosophila g protein coupled receptors, nucleic acids, and mehtods related to the same
10/02/2008US20080241960 Insulin-like growth factor binding protein specific monoclonal antibody for use in diagnosis, prevention and treatment of cell proliferative, inflammatory, autoimmune, muscular and vision disorders
10/02/2008US20080241946 Kit which determines concentration of phosphate metabolizing protein and utilizes profile as indicator of hypo/hyperphosphatemic disorders
10/02/2008US20080241283 Aqueous extracts of anoectochilus spp. kinsenoside-comprising pharmaceutical compositions useful for hepatoprotection and uses of the same
10/02/2008US20080241279 Materials and methods of using calcium for reduction of inflammation
10/02/2008US20080241261 Tablets utillizing polyvinylpyrrolidone finely dispersed in polyvinyl acetate; high dosage levels; applicable to drugs, nutraceuticals, vitamins, minerals, trace elements
10/02/2008US20080241239 Pharmaceutical Tablets Having a Separation Mark Positioned on the Side of Said Tablets
10/02/2008US20080241165 Controlling extracellular protein degradation and/or clearance via modulation of tissue plasminogen activator activity; treating diabetic, autoimmune, cardiovascular, blood and nervous system disorders
10/02/2008US20080241158 G-protein coupled receptors for use in identifying modulators for treatment and prevention of cell proliferative, neurological, cardiovascular, gastrointestinal, autoimmune/inflammatory, metabolic and viral disorders
10/02/2008US20080241107 Using transdifferentiated stem cells to treat diabetes; tissue engineering; regenerative medicine; tissue repair
10/02/2008US20080241099 Inhibitors of MBP 85-99 or proteolipid protein (PLP) 40-60-specific HLA-DR-2-restricted T cell clones; multiple sclerosis; rheumatoid arthritis; solid phase synthesis; kits
10/02/2008US20080241094 An oral dosage form containing a polymer that swells upon absorbing water from gastric fluid to increase its size thereby promoting its gastric retention, maintains its physical integrity in a stomach for at least 2 hours, and is degradable by an intestinal enzyme or exposure to an intestinal pH
10/02/2008US20080241093 A potassium-binding polymer of a crosslinked ion exchange polymer having acid groups and an alpha/beta electronegative group in a bead form as an oral dosage; renal insufficiency; congestive heart failure; hyperkalemia; high preferential binding capaciity; stability; nonabsorbent; nontoxic
10/02/2008CA2719711A1 Vector encoding therapeutic polypeptide and safety elements to clear transduced cells
10/02/2008CA2684655A1 Oral pharmaceutical preparation for colon-specific delivery
10/02/2008CA2682763A1 Methods and kits for administering probiotics
10/02/2008CA2682039A1 Cosmetic preparations designed to reduce unsightly cellulite
10/02/2008CA2681775A1 A vaccine preventing and/or treating autoimmune diseases
10/02/2008CA2681766A1 Multivalent heterobifunctional polymers and methods of their use
10/02/2008CA2681695A1 2-aminopyridine analogs as glucokinase activators
10/02/2008CA2680775A1 Aza-pyridopyrimidinone derivatives
10/02/2008CA2680517A1 Novel pyridinecarboxylic acid (2-aminophenyl)amide derivative having urea structure
10/02/2008CA2677636A1 Probiotics for reduction of risk of obesity
10/01/2008EP1975177A1 An appetite-suppressing peptide, its compositions and use
10/01/2008EP1975176A1 Novel glp-1 fusion peptides, their production and use
10/01/2008EP1975168A1 Pyrazole carboxamide derivatives, pharmaceutical compositions and its preparation
10/01/2008EP1975164A2 Octahydrobenzimidazolone compounds as analgetics
10/01/2008EP1974752A1 Subcellular targeting of therapeutic proteins
10/01/2008EP1974737A1 Composition for the treatment of diabetes mellitus and metabolic syndrome
10/01/2008EP1974736A1 A composition for the treatment of diabetes mellitus
10/01/2008EP1974734A1 Probiotics for reduction of risk of obesity
10/01/2008EP1974728A1 Lipid metabolism improving composition
10/01/2008EP1973918A2 Derivatives of beta-amino acid as dipeptidyl peptidase-iv inhibitors
10/01/2008EP1973885A1 Aminopyrimidine derivatives inhibiting protein kinase activity, method for the preparation thereof and pharmaceutical composition containing same
10/01/2008EP1973555A2 Processes for obtaining lignan extracts and compositions containing the lignan extracts
10/01/2008EP1973548A2 Soft protease inhibitors and pro-soft forms thereof
10/01/2008EP1973542A2 Treatment of cachexia with statins
10/01/2008EP1973541A2 Use of benzo-fused heterocycle sulfamide derivatives for lowering lipids and lowering blood glucose levels
10/01/2008EP1973427A2 Compositions comprising one or more phytosterols and/or phytostanols, or derivatives thereof, and high hlb emulsifiers
10/01/2008EP1622903B1 Cannabinoid receptor ligands and uses thereof
10/01/2008EP1515717B1 Calcium salts of indole derived statins
10/01/2008EP1496877B1 Method and composition for treatment of diabetes, hypertension, chronic heart failure and fluid retentive states
10/01/2008EP1331935B1 Derivatives of tryptamine and analogous compounds, and pharmaceutical formulations containing them
10/01/2008EP1251862B1 Ophthalmic compositions for treating ocular hypertension
10/01/2008EP1224160B1 Process for the preparation of the polymorphic form II of sertraline hydrochloride
10/01/2008EP1212295B1 Substituted alpha-hydroxy acid caspase inhibitors and the use thereof
10/01/2008EP1142590B1 Gene therapy for diabetic ischemic disease
10/01/2008EP0739207B1 Enteral formula with ribo-nucleotides
10/01/2008CN101277965A N-phenyl benzamide derivatives as sirtuin modulators
10/01/2008CN101277963A Benzimidazole derivatives as SIRTUIN modulators
10/01/2008CN101277960A Acylated spiropiperidine derivatives as melanocortin-4 receptor modulators
10/01/2008CN101277940A 4-oxy-n-[1,3,4]-thiadiazol-2-yl-benzene sulfonamides, processes for their preparation and their use as pharmaceuticals
10/01/2008CN101277932A Aryl-substituted nitrogen-containing heterocyclic compound
10/01/2008CN101277930A Anti-hypercholesterolemic compounds
10/01/2008CN101277722A Composition and method for prevention and treatment of type I diabetes
10/01/2008CN101277719A Medical agent containing insulin resistance improving agent
10/01/2008CN101277710A Antiobesity composition
10/01/2008CN101277705A Agent for amelioration of insulin resistance
10/01/2008CN101277688A Formulation comprising metformin and vildagli ptin
10/01/2008CN101277687A Therapeutic agent for liver disease containing 2-amino-1,3-propanediol derivative as active ingredient and therapeutic method for liver disease
10/01/2008CN101275158A Screening preparation for superior enterococcus faecalis and application thereof
10/01/2008CN101275136A Polypeptides controlling phosphoric acid metabolism, calcium metabolism, calcification and vitamin d metabolism and DNAs encoding the same
10/01/2008CN101274962A Antibodies against human IL-12
10/01/2008CN101274953A Method for extracting corosolic acid from plant
10/01/2008CN101274934A Medicaments with HM74a receptor activity
10/01/2008CN101274927A Photochemical reaction preparation for quaternary ring compound and use of the quaternary ring compound
10/01/2008CN101274918A Substitutive five membered heterocyclic compound, preparation and medical use thereof
10/01/2008CN101274084A Medicament for curing hypertension, hyperlipemia and complication thereof
10/01/2008CN101274078A Natural plant extract and preparing method and application of the same
10/01/2008CN101274072A Compound formulation of safe fat-reducing tablet for solving carbohydrates intolerance and producing process
10/01/2008CN101274046A Chinese medicine for curing adiposity
10/01/2008CN101274042A Medicament composition for curing hyperlipemia and method of preparing the same
10/01/2008CN101274041A Health care food for reducing blood fat and weight and preparation method thereof
10/01/2008CN101274040A Chitin capsule and technique for producing and preparing thereof
10/01/2008CN101274039A Tea pigment sustained-release dropping pills and method of preparing the same
10/01/2008CN101274033A Medicament composite for diabetes mellitus and preparation method thereof
10/01/2008CN101274023A Pharmaceutical combination for preventing birth-defect and improving memory
10/01/2008CN101274022A Pharmaceutical combination for preventing birth-defect and improving memory
10/01/2008CN101274021A Pharmaceutical combination for preventing birth-defect and improving memory
10/01/2008CN101274020A Pharmaceutical combination for preventing birth-defect and improving memory
10/01/2008CN101274019A Pharmaceutical combination for preventing birth-defect and improving memory
10/01/2008CN101274016A Compound formulation of capsules for reducing blood sugar, blood fat and blood pressure and preparing technique
10/01/2008CN101274012A Composition of Prunella plant extracts, preparation and pharmaceutical use thereof
10/01/2008CN101274007A Pharmaceutical combination of prepotency for preventing birth-defect and improving memory
10/01/2008CN101274006A Pharmaceutical combination of prepotency for preventing birth-defect and improving memory
10/01/2008CN101274005A Pharmaceutical combination of prepotency for preventing birth-defect and improving memory
10/01/2008CN101274004A Pharmaceutical combination of prepotency for preventing birth-defect and improving memory
10/01/2008CN101274003A Pharmaceutical combination of prepotency for preventing birth-defect and improving memory
10/01/2008CN101274002A Pharmaceutical combination of prepotency for preventing birth-defect and improving memory
10/01/2008CN101273994A Pharmaceutical composition for curing diabetic retina pathological changes and method of preparing the same
10/01/2008CN101273987A Use of substituted cyanopyrrolidines and combination preparations containing them for treating hyperlipidemia and associated diseases
10/01/2008CN101273981A Preparation and method for treating diabetes
10/01/2008CN101273794A Hypoglycemic and thirst-relieving health-care tea
10/01/2008CN101273789A Summer-heat clearing beverage and its preparing method
10/01/2008CN101273787A Pure Chinese medicinal health care black-bone chicken
10/01/2008CN101273774A Bitter-buckwheat tea and preparation method thereof
1 ... 479 480 481 482 483 484 485 486 487 488 489 490 491 492 493 494 495 496 497 498 499 ... 1298